Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study

Background: The pandemic of coronavirus disease 2019 (COVID-19) resulted in grave morbidity and mortality worldwide. There is currently no effective drug to cure COVID-19. Based on analyses of available data, we deduced that excessive prostaglandin E(2) (PGE(2)) produced by cyclooxygenase-2 was a ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Wenxin, Chen, Yan, You, Kai, Tan, Shenglin, Wu, Feima, Tao, Jiawang, Chen, Xudan, Zhang, Jiaye, Xiong, Yue, Yuan, Fang, Yang, Zhen, Chen, Tingting, Chen, Xinwen, Peng, Ping, Tai, Qiang, Wang, Jian, Zhang, Fuchun, Li, Yin-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703865/
https://www.ncbi.nlm.nih.gov/pubmed/33312125
http://dx.doi.org/10.3389/fphar.2020.561674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703865/
https://www.ncbi.nlm.nih.gov/pubmed/33312125
http://dx.doi.org/10.3389/fphar.2020.561674

Ejemplares similares